ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Mol Pharm Org Process Res 2015, Vol 3(1): 123
  • DOI: 10.4172/2329-9053.1000123

In Vitro Synergism Testing of Three Antimicrobial Agents against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis by Checkerboard Method

Liping Yan, Linlin Zhang, Hua Yang and Heping Xiao*
Department of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, China
*Corresponding Author : Heping Xiao, Department of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, School Of Medicine, 507 Zhengmin Rd., Shanghai 200433, People’s Republic of China, Tel: 86-21-65115006, Fax: 86- 21-65111298, Email: xiaoheping_sars@163.com

Received Date: Dec 17, 2014 / Accepted Date: Jan 06, 2015 / Published Date: Jan 15, 2015

Abstract

Objective: In view of the national key project for infectious diseases “the retreatment research of tuberculosis”, we determined the in vitro anti-mycobacterial activity of four drugs in the treatment, pasiniazid (Pa), moxifloxacin (Mfx), Rifabutin (Rfb) and rifapentini (Rft) in combination to multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis.

Method: Three-dimensional checkerboard in Middlebrook 7H9 broth microdilutions was used to detect the fractional inhibitory concentration index (FICI) of anti-tuberculosis drug combination (MfxPa, MfxPaRfb and MfxPaRft) to twenty clinical isolates of Mycobacterium tuberculosis, including ten multidrug-resistant isolates and ten extensively drug-resistant isolates. The test results were interpreted by calculating the FICI to judge the in vitro synergy, with FICI <0. 5 and FICI <0.75 as the basis of two drugs and three drugs have synergy.

Results: The FICI range of MfxPa combination for multidrug-resistant isolates and ten extensively drug-resistant isolates was 0.28-1, only three isolates <0.5, showed synergistic effect. The FICI range of MfxPaRfb combination for ten isolates of multidrug-resistant isolates was from 0.31 to 1.25, two isolates <0.75, showed synergistic effect and for ten isolates of extensively drug-resistant isolates was from 0.53 to 1.25, five isolates <0.75, showed synergistic effect. The FICI range of MfxPaRft combination for ten isolates of multidrug-resistant isolates was from 0.16 to 0.655, all showed synergistic effect and for ten isolates of extensively drug-resistant isolates was from 0.34 to 1.68, five isolates <0.75, showed synergistic effect.

Conclusion: The synergism of MfxPa combination was poor. When a third agent (Rfb or Rft) was added to the combination, the synergistic effect was better. The MfxPaRft combination showed better synergism than MfxPaRfb combination.

Keywords: Multidrug-resistant M. tuberculosis; Extensively drugresistant M. tuberculosis; In vitro synergy; Fractional inhibitory concentration index; Broth microdilution checkerboard

Citation: Yan L, Zhang L, Yang H, Xiao H (2015) In Vitro Synergism Testing Of Three Antimicrobial Agents against Multidrug-Resistant and Extensively Drug- Resistant Mycobacterium Tuberculosis by Checkerboard Method. J Mol Pharm Org Process Res 2: 123. Doi: 10.4172/2329-9053.1000123

Copyright: ©2015 Yan L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top